Search results
Regeneron (REGN), Sanofi's Dupixent Succeeds in 2nd COPD Study
Zacks via Yahoo Finance· 6 months agoRegeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced positive study data on the...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Sanofi's (SNY) Dupixent Gets FDA Nod for Eczema in Infants
Zacks via Yahoo Finance· 2 years agoSanofi (SNY) and partner Regeneron's label expansion application for Dupixent to include infants...
Sanofi's (SNY) Dupixent Gets Europe Nod for Prurigo Nodularis
Zacks via Yahoo Finance· 1 year agoSanofi SNY and partner Regeneron REGN announced that the European Commission (EC) approved their...
Sanofi (SNY) Dupixent Esophagitis Kids Study Meets Goal
Zacks via Yahoo Finance· 2 years agoSanofi's (SNY) Dupixent shows the potential to improve signs of eosinophilic esophagitis in a phase...
When my daughter's asthma medication doubled in cost, I learned we weren't the only ones paying a...
INSIDER via Yahoo News· 11 months agoGetty Images I was shocked when my daughter's monthly asthma prescription costs doubled. I learned...
Sanofi (SNY) Dupixent Gets CHMP Nod to Eosinophilic Esophagitis
Zacks via Yahoo Finance· 1 year agoThe CHMP recommends approval of Sanofi (SNY) and partner Regeneron's Dupixent for the treatment of...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
Regeneron, Sanofi Plot A Major Expansion That Could Add $4 Billion In Future Sales
Investor's Business Daily· 6 months agoRegeneron Pharmaceuticals and Sanofi said Monday their blockbuster drug, Dupixent, significantly...
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo Finance· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...